Exin Therapeutics vs GIBION AI: Revenue, Funding & Team Size Compared
Exin Therapeutics generates $550K in revenue; GIBION AI generates $550K. Exin Therapeutics and GIBION AI are close to the same size by revenue. The table below compares Exin Therapeutics and GIBION AI on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  Exin TherapeuticsThis company |  GIBION AI |
|---|---|---|
| Revenue | $550K | $550K |
| Team size | 5 | 5 |
| Founded | 2025 | 2023 |
| HQ | San Francisco, United States | Berlin, Germany |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Exin Therapeutics at a glance
Exin Therapeutics generates $550K in revenue with 5 employees, headquartered in San Francisco, United States.
- Revenue
- $550K
- Team size
- 5
- Founded
- 2025
AI drug discovery platform for neurotherapeutics
GIBION AI at a glance
GIBION AI generates $550K in revenue with 5 employees, headquartered in Berlin, Germany.
- Revenue
- $550K
- Team size
- 5
- Founded
- 2023
Making AI accessible and scalable
Other Exin Therapeutics alternatives
Exin Therapeutics competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Exin Therapeutics vs GIBION AI: frequently asked questions
Is Exin Therapeutics or GIBION AI bigger?
Exin Therapeutics is the bigger company by revenue, at $550K against $550K for GIBION AI.
How much revenue does Exin Therapeutics make?
Exin Therapeutics generates $550K in annual revenue with a team of 5.
How much revenue does GIBION AI make?
GIBION AI generates $550K in annual revenue with a team of 5.